Bulletin
Investor Alert

InflaRx N.V.

NAS: IFRX

GO
/marketstate/country/us

Market closed

/zigman2/quotes/209883736/composite

$

1.44

Change

-0.06 -4.00%

Volume

Volume 53,317

May 20, 2022, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/209883736/composite

Previous close

$ 1.50

$ 1.44

Change

-0.06 -4.00%

Day low

Day high

$1.40

$1.50

Open
Open: 1.49

52 week low

52 week high

$1.31

$5.69

Open

Market cap

$63.65M

Average volume

243,531

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.27

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ifrx

MarketWatch News on IFRX

  1. InflaRx upgraded to strong buy from outperform at Raymond James

    7:57 a.m. Oct. 28, 2021

    - Tomi Kilgore

  2. InflaRx upgraded to outperform from market perform at Raymond James

    8:24 a.m. April 30, 2020

    - Tomi Kilgore

  3. 4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens

    9:06 p.m. March 6, 2020

    - Barron's Online

  4. InflaRx downgraded to market perform at BMO Capital

    10:04 a.m. June 6, 2019

    - Tomi Kilgore

  5. InflaRx downgraded to hold from buy at SunTrust RH

    8:35 a.m. June 6, 2019

    - Tomi Kilgore

  6. InflaRx stock price target cut to $5 from $55 at SunTrust RH

    8:35 a.m. June 6, 2019

    - Tomi Kilgore

  7. InflaRx downgraded to market perform from outperform at Raymond James

    3:54 p.m. June 5, 2019

    - Tomi Kilgore

  8. InflaRx stock price target cut to $4 from $67 at SVB Leerink

    1:02 p.m. June 5, 2019

    - Tomi Kilgore

  9. InflaRx downgraded to market perform from outperform at SVB Leerink

    1:02 p.m. June 5, 2019

    - Tomi Kilgore

  10. Cronos Group and Campbell Soup Stock Rise as the Dow Pops Again

    6:22 p.m. June 5, 2019

    - Barron's Online

  11. InflaRx stock tumbles 82% after reporting disappointing trial results

    7:54 a.m. June 5, 2019

    - Ciara Linnane

  12. InflaRx stock price target raised to $67 vs. $65 at JPMorgan

    8:08 a.m. May 24, 2019

    - Ciara Linnane

  13. InflaRx price target raised to $44 vs. $42 at Raymond James

    7:44 a.m. May 24, 2019

    - Ciara Linnane

  14. InflaRx stock price target raised to $67 from $42 at SVB Leerink

    7:49 a.m. April 10, 2019

    - Tomi Kilgore

  15. InflaRx stock price target raised to $65 from $42 at J.P. Morgan

    9:14 a.m. Feb. 5, 2019

    - Tomi Kilgore

  16. Samsung Warns on Revenue, but Trade Hopes Lift Global Stocks

    9:25 a.m. Jan. 8, 2019

    - Barron's Online

  17. InflaRx started at buy with $55 stock price target at SunTrust RH

    7:50 a.m. June 28, 2018

    - Tomi Kilgore

  18. InflaRx started at overweight with $30 stock price target at J.P. Morgan

    9:13 a.m. Dec. 4, 2017

    - Tomi Kilgore

  19. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ifrx

Other News on IFRX

  1. IQ, FUTU and VYNT among pre market losers

    8:54 a.m. March 31, 2022

    - Seeking Alpha

  2. GTE, EIGR and AQST among pre market gainers

    8:39 a.m. March 17, 2022

    - Seeking Alpha

  3. Inflarx (IFRX) Investor Presentation - Slideshow

    5:14 p.m. Jan. 15, 2022

    - Seeking Alpha

  4. Our First Look At InflaRx

    5:56 p.m. Dec. 29, 2021

    - Seeking Alpha

  5. TDOC, VXRT and CDOX among pre market gainers

    9:25 a.m. Nov. 26, 2021

    - Seeking Alpha

  6. TRIT and SYTA among mid-day movers

    1:59 p.m. Oct. 28, 2021

    - Seeking Alpha

  7. HIVE, HUT and DWAC among pre market gainers

    8:32 a.m. Oct. 28, 2021

    - Seeking Alpha

  8. DGLY, PHUN and BPTH among pre market gainers

    8:31 a.m. Oct. 27, 2021

    - Seeking Alpha

  9. AG, FRO and WATT among pre market gainers

    8:33 a.m. Oct. 19, 2021

    - Seeking Alpha

  10. RRD, ATNX and NXTP among premarket gainers

    8:23 a.m. Oct. 12, 2021

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/ifrx

Press Releases on IFRX

  1. InflaRx Reports Full Year 2021 Financial and Operating Results

    7:30 a.m. March 24, 2022

    - GlobeNewswire

  2. InflaRx Announces New Pipeline Program - Oral C5aR Inhibitor

    8:30 a.m. Jan. 10, 2022

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.